News

News stories

Professor Dame Pamela Shaw
Professor Dame Pamela Shaw

World-renowned MND researcher and clinician says making research easier to understand, and showing why it matters, is vital

One of the world’s leading scientists on motor neurone disease (MND) and other neurological diseases says making complex research more accessible and understandable is vital to show progress is being made at developing treatments for the conditions.
DNA strand

FDA approves trial to advance pioneering treatment for Hereditary Spastic Paraplegia (HSP)

The US Food and Drug Administation (FDA) has approved BlackfinBio Limited’s Phase 1/2 clinical trial for its novel adeno-associated virus (AAV) gene therapy targeting Hereditary Spastic Paraplegia (HSP) Type 47 (SPG47).
DNA strands

΢ÃÜȦ spinout takes major step towards advancing pioneering treatments for Hereditary Spastic Paraplegia (HSP)

BlackfinBio Limited is a spinout company from the University of ΢ÃÜȦ set to pioneer novel therapies for rare genetic neurological diseases.

Image of motor neurones

Groundbreaking EXPERTS-ALS study for MND treatments

The EXPErimental medicine Route To Success in ALS (EXPERTS-ALS) project aims to rapidly screen potential drugs for evidence that they can slow down damage to the nervous system occurring in people with motor neuron disease
Her Majesty The Queen with Professor Dame Pamela Shaw at the opening of SITraN in 2010

Royal recognition for neuroscience research at the University of ΢ÃÜȦ

Neuroscience research at the University of ΢ÃÜȦ has been recognised by Her Majesty The Queen with the Queen’s Anniversary Prize for delivering real benefits in improving outcomes for people living with some of the most devastating neurodegenerative diseases.
Chronic nerve pain

The link between cell ‘dark matter’ and chronic nerve pain

Our researchers have found a link between neuropathic pain and ‘dark matter’ in cells, which could lead to new treatments for patients with chronic nerve pain.
SITraN Building

Scientists awarded funding for pioneering dementia research

The new research projects will explore the processes behind Alzheimer’s and dementia which could lead to new approaches in how they are treated.
Test tubes

A new treatment for Parkinson’s disease

A ΢ÃÜȦ academic has been awarded funding to develop a new treatment for Parkinson’s disease, that could potentially slow, or even stop its progression.

MRC Festival of Medical Research 2019

On 15 and 16 June 2019, scientists from the Hearing Research Group at the University of ΢ÃÜȦ’s Neuroscience Institute shared their latest research on hearing and hearing loss.